Cancer R&D 2024 has wrapped up successfully. We’re grateful for your interest and interaction with Alfa Cytology. We’re eager to continue providing our expertise in cancer drug development. Let’s look back on these memorable moments!
Learn More
Breast cancer cell analysis examines and characterizes breast cancer cells to understand their behavior, treatment responses, and mechanisms. Alfa Cytology offers a comprehensive suite of breast cancer cell analysis services.
Cancer cells within breast tumors have heterogeneous phenotypes and exhibit dynamic plasticity, and it is particularly important to accurately assess this heterogeneity and its impact on outcomes and drug response. Alfa Cytology provides multi-dimensional cell analysis services, including breast cancer stem cells, circulating tumor cells, rare cell analysis, breast cell microarrays, and flow cytometry analysis services. Our goal is to provide you with more information about the mechanisms of breast cancer initiation, progression, and metastasis.
BC is a highly heterogeneous disease, and the biological characteristics of tumors in different individuals or even in the same body are different. Therefore, it is necessary to establish various types of BC tumor models to achieve precise and individualized treatment of BC. Alfa Cytology has many years of experience in building BC models, based on our advanced platform and experienced scientists, we can build customized, cost-effective, high-quality BC models, including BC animal models, BC organoids models, and BC cell models.
| Services | Description |
|---|---|
| Breast cancer stem cell analysis | The study of BCSC requires the use of cellular and molecular tools to monitor the genomic integrity of cells and track the expression of proteins associated with pluripotency. Confirm differentiation status by analyzing key genetic and protein markers to ensure the correct cell type is identified and propagated. We can help you isolate and culture BCSCs and conduct multi-faceted analysis to meet your different research needs. |
| Breast cancer CTC detection services | Provide flexible and fast CTC detection solutions, including CTC separation and CTC detection. The sensitivity of CTC detection is better than that of traditional imaging examinations, and the presence of tumor cells can be detected 1 - 4 years earlier than imaging examinations. Compared with pathological tissue biopsy, CTC detection does not rely on the existence of lesions, sampling is convenient, and real-time dynamic monitoring can be performed. |
| Breast cancer cellular microarray analysis | Cellular microarray technology identifies specific human plasma membrane and secreted proteins targeted by antibodies, proteins, small molecules, viruses, chimeric antigen receptor cells, and other ligands. It provides a highly sensitive and specific platform for breast cancer cell systems biology research and drug screening. |
| Breast cancer rare cell analysis | Our technology fully automatically captures, images, and counts rare cells (including circulating tumor cells, CTCs, and rare immune cells) in whole blood, analyzes biomarkers, and extracts viable cells for downstream research. Whole blood samples can be analyzed directly with minimal cell loss. |
| Breast cancer flow cytometry analysis | We can use flow cytometry technology to help you perform cell sorting, cellular immunophenotyping analysis, multi-cytokine detection, cell function testing, detection of cell surface antigen expression, analysis of cell proliferation, cell differentiation, apoptosis, etc. |
Alfa Cytology boasts extensive expertise in BC research garnered over many years. We are committed to continuous innovation, perpetually exploring improved solutions for our clientele, and ensuring the delivery of top-notch products and services. If you are interested in learning more about our BC cell analysis services, please don't hesitate to contact us. Our dedicated and knowledgeable staff will promptly get in touch with you.